Go to content
UR Home

Bristol-Myers Squibb (BMS) Immune Oncology Foundation (Award FA19-009)

Up a level
Export as
[feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Date | Creators | Item type | No Grouping
Number of items: 3.

Glehr, Gunther , Riquelme, Paloma, Yang Zhou, Jordi, Cordero, Laura, Schilling, Hannah-Lou, Kapinsky, Michael, Schlitt, Hans J., Geissler, Edward K., Burkhardt, Ralph , Schmidt, Barbara, Haferkamp, Sebastian, Hutchinson, James A. and Kronenberg, Katharina (2022) External validation of biomarkers for immune-related adverse events after immune checkpoint inhibition. Frontiers in Immunology 13, p. 1011040.

Schilling, Hannah‐Lou, Hutchinson, James A. and Haferkamp, Sebastian (2022) Prediction of immune checkpoint blockade‐related hepatitis in metastatic melanoma patients. JDDG: Journal der Deutschen Dermatologischen Gesellschaft 20 (6), pp. 773-775.

Schilling, Hannah-Lou, Glehr, Gunther , Kapinsky, Michael, Ahrens, Norbert , Riquelme, Paloma , Cordero, Laura, Bitterer, Florian, Schlitt, Hans J. , Geissler, Edward K. , Haferkamp, Sebastian, Hutchinson, James A. and Kronenberg, Katharina (2021) Development of a Flow Cytometry Assay to Predict Immune Checkpoint Blockade-Related Complications. Frontiers in Immunology 2021 (12), pp. 1-12. Fulltext restricted.

This list was generated on Sun May 19 22:36:53 2024 CEST.
  1. Homepage UR

University Library

Publication Server

Contact:

Publishing: oa@ur.de
0941 943 -4239 or -69394

Dissertations: dissertationen@ur.de
0941 943 -3904

Research data: datahub@ur.de
0941 943 -5707

Contact persons